The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-butyl-N-(3-((2-methyl-1H-imidazol-5-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)benzenesulfonamide ID: ALA1079187
PubChem CID: 46882396
Max Phase: Preclinical
Molecular Formula: C25H32N4O2S
Molecular Weight: 452.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cnc(C)[nH]2)CC3)cc1
Standard InChI: InChI=1S/C25H32N4O2S/c1-3-4-5-20-6-10-25(11-7-20)32(30,31)28-23-9-8-21-12-14-29(15-13-22(21)16-23)18-24-17-26-19(2)27-24/h6-11,16-17,28H,3-5,12-15,18H2,1-2H3,(H,26,27)
Standard InChI Key: IEWQTFGFLPFFRK-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
12.5083 -26.7755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5070 -27.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2183 -28.0129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2163 -26.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8532 -27.1626 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4302 -26.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5936 -26.2308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4921 -27.9595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6498 -28.1601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9383 -27.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9327 -26.7714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7937 -28.0115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0815 -27.5990 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.4857 -26.8852 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6627 -26.8852 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3654 -28.0054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6558 -27.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9403 -27.9913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9338 -28.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6488 -29.2323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3616 -28.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2186 -29.2228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5083 -28.8070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7931 -29.2142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0829 -28.7983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7488 -27.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2225 -27.8934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9732 -28.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7127 -29.2570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4227 -28.7102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1219 -27.8661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2825 -28.9630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
13 16 1 0
16 17 2 0
5 6 1 0
17 18 1 0
6 7 1 0
18 19 2 0
5 8 1 0
19 20 1 0
9 10 1 0
20 21 2 0
21 16 1 0
10 11 1 0
19 22 1 0
11 7 1 0
22 23 1 0
8 9 1 0
23 24 1 0
2 3 1 0
24 25 1 0
2 12 1 0
5 26 1 0
3 10 2 0
26 27 1 0
27 28 2 0
12 13 1 0
1 2 2 0
13 14 2 0
11 4 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 27 1 0
13 15 2 0
30 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 452.62Molecular Weight (Monoisotopic): 452.2246AlogP: 4.46#Rotatable Bonds: 8Polar Surface Area: 78.09Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.41CX Basic pKa: 7.79CX LogP: 3.67CX LogD: 3.34Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.53Np Likeness Score: -1.36
References 1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.. (2009) The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor., 19 (22): [PMID:19804969 ] [10.1016/j.bmcl.2009.09.027 ]